Literature DB >> 27265405

Predispositions to Lymphoma: A Practical Review for Genetic Counselors.

Morgan Similuk1, V Koneti Rao2, Jane Churpek3, Michael Lenardo2.   

Abstract

This review provides a synopsis for genetic counselors of the major concepts of lymphoma predisposition: genomic instability, immune deficiency, inappropriate lymphoproliferation, and chronic antigen stimulation. We discuss syndromes typifying each of these mechanisms. Importantly, our review of the genetic counseling literature reveals sparse discussion of genetically-based immune-mediated lymphoma predisposition, which we address in depth here. We aim to increase awareness among genetic counselors and colleagues in oncology about familial susceptibility and facilitate critical thinking about lymphoma risk assessment. Clinical application of this knowledge is aided by recommendations for collection of personal and family history to guide risk assessment and testing. Lastly, we include a special discussion of genetic counseling issues including perceptions of the context, nature, and magnitude of lymphoma risk, as well as coping with awareness of susceptibility to lymphoma.

Entities:  

Keywords:  Cancer; Genetic counseling; Heredity; Immunology; Lymphoma; Mechanism; Predisposition; Risk assessment

Mesh:

Year:  2016        PMID: 27265405     DOI: 10.1007/s10897-016-9979-0

Source DB:  PubMed          Journal:  J Genet Couns        ISSN: 1059-7700            Impact factor:   2.537


  79 in total

Review 1.  Re-conceptualizing risk in genetic counseling: implications for clinical practice.

Authors:  Jehannine C Austin
Journal:  J Genet Couns       Date:  2010-01-30       Impact factor: 2.537

2.  High incidence of Epstein-Barr virus (EBV)-positive Hodgkin lymphoma and Hodgkin lymphoma-like B-cell lymphoproliferations with EBV latency profile 2 in children with interleukin-2-inducible T-cell kinase deficiency.

Authors:  Kirsten Bienemann; Arndt Borkhardt; Wolfram Klapper; Ilske Oschlies
Journal:  Histopathology       Date:  2015-04-30       Impact factor: 5.087

3.  Helping patients decide: ten steps to better risk communication.

Authors:  Angela Fagerlin; Brian J Zikmund-Fisher; Peter A Ubel
Journal:  J Natl Cancer Inst       Date:  2011-09-19       Impact factor: 13.506

Review 4.  XMEN disease: a new primary immunodeficiency affecting Mg2+ regulation of immunity against Epstein-Barr virus.

Authors:  Feng-Yen Li; Benjamin Chaigne-Delalande; Helen Su; Gulbu Uzel; Helen Matthews; Michael J Lenardo
Journal:  Blood       Date:  2014-02-18       Impact factor: 22.113

5.  DOCK8 deficiency: clinical and immunological phenotype and treatment options - a review of 136 patients.

Authors:  Susanne E Aydin; Sara Sebnem Kilic; Caner Aytekin; Ashish Kumar; Oscar Porras; Leena Kainulainen; Larysa Kostyuchenko; Ferah Genel; Necil Kütükcüler; Neslihan Karaca; Luis Gonzalez-Granado; Jordan Abbott; Daifulah Al-Zahrani; Nima Rezaei; Zeina Baz; Jens Thiel; Stephan Ehl; László Marodi; Jordan S Orange; Julie Sawalle-Belohradsky; Sevgi Keles; Steven M Holland; Özden Sanal; Deniz C Ayvaz; Ilhan Tezcan; Hamoud Al-Mousa; Zobaida Alsum; Abbas Hawwari; Ayse Metin; Susanne Matthes-Martin; Manfred Hönig; Ansgar Schulz; Capucine Picard; Vincent Barlogis; Andrew Gennery; Marianne Ifversen; Joris van Montfrans; Taco Kuijpers; Robbert Bredius; Gregor Dückers; Waleed Al-Herz; Sung-Yun Pai; Raif Geha; Gundula Notheis; Carl-Philipp Schwarze; Betül Tavil; Fatih Azik; Kirsten Bienemann; Bodo Grimbacher; Valerie Heinz; H Bobby Gaspar; Roland Aydin; Beate Hagl; Benjamin Gathmann; Bernd H Belohradsky; Hans D Ochs; Talal Chatila; Ellen D Renner; Helen Su; Alexandra F Freeman; Karin Engelhardt; Michael H Albert
Journal:  J Clin Immunol       Date:  2015-01-28       Impact factor: 8.317

Review 6.  DOCK8 deficiency.

Authors:  Helen C Su; Huie Jing; Qian Zhang
Journal:  Ann N Y Acad Sci       Date:  2011-12       Impact factor: 5.691

Review 7.  The dual association between lymphoma and autoimmunity.

Authors:  M Ehrenfeld; M Abu-Shakra; D Buskila; Y Shoenfeld
Journal:  Blood Cells Mol Dis       Date:  2001 Jul-Aug       Impact factor: 3.039

Review 8.  The World Health Organization (WHO) classification of the myeloid neoplasms.

Authors:  James W Vardiman; Nancy Lee Harris; Richard D Brunning
Journal:  Blood       Date:  2002-10-01       Impact factor: 22.113

Review 9.  Enhancing informed choice to undergo health screening: a systematic review.

Authors:  Barbara Bowles Biesecker; Marc D Schwartz; Theresa M Marteau
Journal:  Am J Health Behav       Date:  2013-05

Review 10.  Leukemia and lymphoma in ataxia telangiectasia.

Authors:  A M Taylor; J A Metcalfe; J Thick; Y F Mak
Journal:  Blood       Date:  1996-01-15       Impact factor: 22.113

View more
  5 in total

Review 1.  Germline Genetic Predisposition to Hematologic Malignancy.

Authors:  Elissa Furutani; Akiko Shimamura
Journal:  J Clin Oncol       Date:  2017-02-13       Impact factor: 44.544

Review 2.  Hematological Malignancies in Adults With a Family Predisposition.

Authors:  Tilmann Bochtler; Georg-Martin Haag; Sarah Schott; Matthias Kloor; Alwin Krämer; Carsten Müller-Tidow
Journal:  Dtsch Arztebl Int       Date:  2018-12-14       Impact factor: 5.594

Review 3.  Peripheral T cell lymphomas: from the bench to the clinic.

Authors:  Danilo Fiore; Luca Vincenzo Cappelli; Alessandro Broccoli; Pier Luigi Zinzani; Wing C Chan; Giorgio Inghirami
Journal:  Nat Rev Cancer       Date:  2020-04-06       Impact factor: 60.716

Review 4.  Primary Immunodeficiency and Cancer Predisposition Revisited: Embedding Two Closely Related Concepts Into an Integrative Conceptual Framework.

Authors:  Oskar A Haas
Journal:  Front Immunol       Date:  2019-02-12       Impact factor: 7.561

5.  Pancreatic neuroendocrine tumor, lymphoma, and squamous cell carcinoma of hypopharynx; A case report of three primary cancers in one patient.

Authors:  Vorapatu Tangsirapat; Kitti Wongta; Kobkool Chakrapan Na Ayudhya; Vichack Chakrapan Na Ayudhya; Paiboon Sookpotarom
Journal:  Int J Surg Case Rep       Date:  2019-11-02
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.